Literature DB >> 25857640

Improvement in metabolic effects by dietary intervention is dependent on the precise nature of the developmental programming challenge.

C J Bautista1, C Guzmán2, G L Rodríguez-González1, E Zambrano1.   

Abstract

Predisposition to offspring metabolic dysfunction due to poor maternal nutrition differs with the developmental stage at exposure. Post-weaning nutrition also influences offspring phenotype in either adverse or beneficial ways. We studied a well-established rat maternal protein-restriction model to determine whether post-weaning dietary intervention improves adverse outcomes produced by a deficient maternal nutritional environment in pregnancy. Pregnant rats were fed a controlled diet (C, 20% casein) during pregnancy and lactation (CC) or were fed a restricted diet (R, 10% casein isocaloric diet) during pregnancy and C diet during lactation (RC). After weaning, the offspring were fed the C diet. At postnatal day (PND) 70 (young adulthood), female offspring either continued with the C diet (CCC and RCC) or were fed commercial Chow Purina 5001 (I) to further divide the animals into dietary intervention groups CCI and RCI. Another group of mothers and offspring were fed I throughout (III). Offspring food intake was averaged between PND 95-110 and 235-250 and carcass and liver compositions were measured at PND 25 and 250. Leptin (PND 110 and 250) and serum glucose, triglycerides and cholesterol (PND 250) levels were measured. Statistical analysis was carried out using ANOVA. At PND 25, body and liver weights were similar between groups; however, CCC and RCC carcass protein:fat ratios were lower compared with III diet. At PND 110 and 250, offspring CCC and RCC had higher body weight, food intake and serum leptin compared with CCI and RCI. CCI had lower carcass fat and increased protein compared with CCC and improved fasting glucose and triglycerides. Adult dietary intervention partially overcomes adverse effects of programming. Further studies are needed to determine the mechanisms involved.

Entities:  

Keywords:  developmental programming; interventions; leptin; malnutrition; protein

Mesh:

Substances:

Year:  2015        PMID: 25857640     DOI: 10.1017/S2040174415001051

Source DB:  PubMed          Journal:  J Dev Orig Health Dis        ISSN: 2040-1744            Impact factor:   2.401


  5 in total

1.  The effect of characteristics of proteins fed during gestation and lactation on development of metabolic syndrome in dams and male offspring of Wistar rats.

Authors:  A Jahan-Mihan; C A Labyak; A Y Arikawa
Journal:  Obes Sci Pract       Date:  2017-03-10

2.  Efficacy of Restricting Dietary Protein Intake Combined with Buyang Huanwu Decoction in Treating Diabetic Nephropathy and Its Effect on Patients' Inflammatory Factor Levels.

Authors:  Dan Chen; Dan Huang; Taotao Hu; Fang Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-23       Impact factor: 2.629

3.  Different Protein Sources in the Maternal Diet of the Rat during Gestation and Lactation Affect Milk Composition and Male Offspring Development during Adulthood.

Authors:  Claudia J Bautista; Luis A Reyes-Castro; Regina J Bautista; Victoria Ramirez; Ana L Elias-López; Rogelio Hernández-Pando; Elena Zambrano
Journal:  Reprod Sci       Date:  2021-06-22       Impact factor: 3.060

Review 4.  The Role of Maternal Dietary Proteins in Development of Metabolic Syndrome in Offspring.

Authors:  Alireza Jahan-Mihan; Judith Rodriguez; Catherine Christie; Marjan Sadeghi; Tara Zerbe
Journal:  Nutrients       Date:  2015-11-06       Impact factor: 5.717

5.  DHA Supplementation of Obese Rats throughout Pregnancy and Lactation Modifies Milk Composition and Anxiety Behavior of Offspring.

Authors:  Elena Zambrano; Guadalupe L Rodríguez-González; Luis A Reyes-Castro; Claudia J Bautista; Diana C Castro-Rodríguez; Gimena Juárez-Pilares; Carlos A Ibáñez; Alejandra Hernández-Rojas; Peter W Nathanielsz; Sara Montaño; Armando Arredondo; Fengyang Huang; Francisco Bolaños-Jiménez
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.